Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 28,242 | 30,114 | 13,993 | 192,645 | -175,218 |
| Depreciation Amortization | 6,390 | 18,139 | 12,997 | 8,531 | 5,235 |
| Accounts receivable | -212,046 | -56,967 | -9,841 | -2,365 | -2,500 |
| Accounts payable and accrued liabilities | 15,263 | 6,286 | 21,662 | -1,717 | 3,069 |
| Other Working Capital | -61,793 | -18,235 | 20,125 | 38,085 | -7,440 |
| Other Operating Activity | 237,425 | 200,215 | 100,125 | 78,602 | 30,582 |
| Operating Cash Flow | $13,481 | $179,552 | $159,061 | $313,781 | $-146,272 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 115,339 | -796,258 | -774,616 | 347,402 | 118,175 |
| PPE Investments | -2,148 | -22,666 | -15,177 | -12,813 | -7,516 |
| Purchase Of Investment | -136,933 | N/A | N/A | -677,892 | -33,749 |
| Sale Of Investment | N/A | 689,630 | 587,880 | N/A | N/A |
| Investing Cash Flow | $-23,742 | $-129,294 | $-201,913 | $-343,303 | $76,910 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 10,260 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 7,098 | N/A | N/A |
| Debt Repayment | -66,680 | -201,625 | -201,625 | N/A | 0 |
| Common Stock Issued | 51,930 | 270,371 | 269,864 | 269,641 | 25,634 |
| Other Financing Activity | 0 | -5,000 | -5,000 | -156,625 | -5,000 |
| Financing Cash Flow | $-14,750 | $74,006 | $70,337 | $113,016 | $20,634 |
| Exchange Rate Effect | 106 | -401 | -377 | -470 | -68 |
| Beginning Cash Position | 226,548 | 102,685 | 102,685 | 102,685 | 102,685 |
| End Cash Position | 201,643 | 226,548 | 129,793 | 185,709 | 53,889 |
| Net Cash Flow | $-24,905 | $123,863 | $27,108 | $83,024 | $-48,796 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,481 | 179,552 | 159,061 | 313,781 | -146,272 |
| Capital Expenditure | -2,148 | -22,666 | -15,177 | -12,813 | -7,516 |
| Free Cash Flow | 11,333 | 156,886 | 143,884 | 300,968 | -153,788 |